Regadenoson

Back to search

Molecule Structure

Scientific Name

Regadenoson

Description of the Drug

Regadenoson is a coronary vasodilator used in radionuclide myocardial perfusion imaging (MPI).

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06213

Brand Name(s)

Lexiscan

Company Owner(s)

Hong Kong King Friend Industrial Co Ltd, Apotex Inc, Hospira Inc, Gland Pharma Ltd, Astellas Pharma Us Inc, International Medication Systems Ltd, Accord Healthcare Inc, Dr Reddys Laboratories Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Adenosine A2a receptor SINGLE PROTEIN AGONIST CHEMBL251

Unichem Links

SureChEMBL SCHEMBL678893
PharmGKB PA166129536
DrugBank DB06213
PubChem: Thomson Pharma 14854126 14927662
PubChem 219024
Nikkaji J1.806.399I
BindingDB 50119132
EPA CompTox Dashboard DTXSID4057712
DrugCentral 2362
ChemicalBook CB0501002
Guide to Pharmacology 5596
rxnorm REGADENOSON REGADENOSON ANHYDROUS
PubChem: Drugs of the Future 12015422
ChEBI 135613
ZINC ZINC000013818943